Visual function, optical disturbance, spectacle independence and patient satisfaction after implantation of trifocal intraocular lens (Acrysof IQ PanOptix) in cataract patients: unilateral versus bilateral implantation.

Not Applicable

• Conditions: H26.9; Cataract, unspecified

• Registration Number: DRKS00029137
• Lead Sponsor: MVZ RHR Augenärzte GmbH Düsseldorf

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2021-10-25
• Study Start: 2022-07-05
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 72

Inclusion Criteria

1. Patients with cataract in both eyes and with a medical indication of a cataract extraction with an implantation of an artificial lens. All the patients have voluntarily and independent from the study decided for a unilateral or bilateral implantation of a trifocal Acrysof IQ PanOptix lens, after a medical enlightenment talk with the treated ophthalmologist. Only capable of consent adults will be included in the study.
2. Age 50-81.
3. No other eye disease.
4. No refractive operation in the patient history.
5. No secondary cataract or already treated secondary cataract with YAG-Laser Kapsulotomy by the time of the evaluation 3 months after the second operation.

Exclusion Criteria

1. Missing patient consent
2. Presence of other eye diseases
3. Postoperative complications that affect the visual aquity
4. Necessity for a re-operation
5. No appearance for the postoperativ evaluation (follow-up).

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The study´s primary ending point is the patients´visual function and their satisfaction. The primary ending point will be measured three months after the second surgery. By that time the following postoperative measurements will take place (visual acuity, contrast sensitivity, twightlight vision, questionnaire included).